Teleallergy: Where Have We Been and Where Are We Going?

J Allergy Clin Immunol Pract. 2022 Sep 2:S2213-2198(22)00870-4. doi: 10.1016/j.jaip.2022.08.032. Online ahead of print.

ABSTRACT

Telemedicine uptake in allergy/immunology was slow before the coronavirus disease 2019 pandemic, but has accelerated since. This review examines where telemedicine has been in allergy/immunology and where it is headed in the future. Focus is placed on patient, physician, and health care professional satisfaction with telemedicine, capacity to expand access to allergy/immunology care, cost considerations, the regulatory environment, and future applications of telemedicine including adherence monitoring, wearable biosensors, artificial intelligence, and machine learning addressed.

PMID:36064184 | DOI:10.1016/j.jaip.2022.08.032